RAPT Therapeutics Inc (RAPT)
1.565
-0.14
(-8.48%)
USD |
NASDAQ |
Nov 13, 16:00
1.565
0.00 (0.00%)
After-Hours: 20:00
RAPT Therapeutics Market Cap: 54.62M for Nov. 13, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2024 | 59.68M |
| November 11, 2024 | 61.08M |
| November 08, 2024 | 100.87M |
| November 07, 2024 | 108.20M |
| November 06, 2024 | 94.94M |
| November 05, 2024 | 85.51M |
| November 04, 2024 | 79.23M |
| November 01, 2024 | 77.83M |
| October 31, 2024 | 74.00M |
| October 30, 2024 | 76.79M |
| October 29, 2024 | 69.81M |
| October 28, 2024 | 67.36M |
| October 25, 2024 | 65.97M |
| October 24, 2024 | 61.78M |
| October 23, 2024 | 60.03M |
| October 22, 2024 | 62.48M |
| October 21, 2024 | 57.42M |
| October 18, 2024 | 62.48M |
| October 17, 2024 | 58.99M |
| October 16, 2024 | 61.08M |
| October 15, 2024 | 63.18M |
| October 14, 2024 | 67.36M |
| October 11, 2024 | 63.52M |
| October 10, 2024 | 58.29M |
| October 09, 2024 | 65.27M |
| Date | Value |
|---|---|
| October 08, 2024 | 65.62M |
| October 07, 2024 | 65.62M |
| October 04, 2024 | 69.81M |
| October 03, 2024 | 69.46M |
| October 02, 2024 | 78.53M |
| October 01, 2024 | 64.57M |
| September 30, 2024 | 70.16M |
| September 27, 2024 | 68.41M |
| September 26, 2024 | 65.27M |
| September 25, 2024 | 61.43M |
| September 24, 2024 | 61.43M |
| September 23, 2024 | 61.43M |
| September 20, 2024 | 62.48M |
| September 19, 2024 | 67.36M |
| September 18, 2024 | 63.52M |
| September 17, 2024 | 66.32M |
| September 16, 2024 | 65.62M |
| September 13, 2024 | 68.06M |
| September 12, 2024 | 67.36M |
| September 11, 2024 | 67.36M |
| September 10, 2024 | 69.46M |
| September 09, 2024 | 70.16M |
| September 06, 2024 | 63.87M |
| September 05, 2024 | 67.36M |
| September 04, 2024 | 71.20M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
54.62M
Minimum
Nov 13 2024
1.189B
Maximum
Jan 06 2022
601.15M
Average
611.85M
Median
Market Cap Benchmarks
| Biomarin Pharmaceutical Inc | 12.70B |
| Arbutus Biopharma Corp | 693.54M |
| GlycoMimetics Inc | 25.72M |
| FibroGen Inc | 33.19M |
| Cidara Therapeutics Inc | 97.90M |
Market Cap Related Metrics
| PS Ratio | 18.57 |
| PEG Ratio | -0.1056 |
| Price to Book Value | 0.5002 |
| Price | 1.565 |
| Earnings Yield | -200.0% |
| PEGY Ratio | -0.1056 |